Introduction {#s1}
============

*Bacteroides fragilis* and *Bacteroides thetaiotaomicron* are members of the normal resident gastrointestinal microbiota, and are important opportunistic pathogens that are capable of causing life-threatening infections such as peritonitis, serious gynaecological sepsis, bacteraemia, and soft tissue and brain abscesses.^[@DKP203C1],[@DKP203C2]^ Metronidazole \[1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole\] is commonly used in the treatment of these anaerobic microbial infections. In addition, it is used for routine prophylaxis during gastrointestinal tract and gynaecological surgery. It is administered as an inert prodrug that is activated intracellularly under anaerobic conditions by the reduction of its nitro group. This generates an active toxic derivative, which causes single- and double-strand DNA breaks.^[@DKP203C3]^ In certain anaerobic protozoa, activation of metronidazole involves a low intracellular redox potential process that results in the reduction of the 5-nitro group forming the transient toxic radicals.^[@DKP203C4]^ The imidazole ring structure is thought to fragment producing two short-lived cytotoxic intermediates, acetamide and *N*-(2-hydroxyethyl)-oxamic acid.^[@DKP203C5]--[@DKP203C7]^ Activation of the drug is likely to occur through interaction with a pyruvate oxidoreductase complex in an ATP-dependent reaction.^[@DKP203C4],[@DKP203C8]^ The pyruvate oxidoreductase complex is formed by a metabolic reaction between pyruvate and the oxidoreductase enzyme to facilitate pyruvate decarboxylation to form acetyl CoA. This reaction generates electrons that are accepted by ferredoxins or flavodoxins that have electron efficiency of −430 or −460 mV.^[@DKP203C5]^ Studies on several *B. fragilis* species suggest that metronidazole activation occurs at a similar pyruvate oxidoreductase complex.^[@DKP203C8]--[@DKP203C10]^ *Bacteroides* spp. can develop resistance to metronidazole via acquisition of nitroimidazole resistance genes (*nim*) that may be encoded on mobile genetic elements (reviewed by Patrick^[@DKP203C11]^). These encode a reductase that converts the nitro group of metronidazole into an amine, thus rendering it inactive.^[@DKP203C3]^

Overexpression of efflux pumps is known to play a role in the resistance of *Bacteroides* spp. to a range of antibiotics.^[@DKP203C1]^ While this may also confer resistance to metronidazole, efflux pump inhibitors did not restore metronidazole susceptibility in a multiresistant *B. fragilis* that lacked *nim* genes,^[@DKP203C12]^ suggesting that there are alternative mechanisms of resistance. In this study, we report the isolation and characterization of a *B. thetaiotaomicron* metronidazole-resistant mutant. We demonstrate for the first time a link between metronidazole resistance, the rhamnose catabolic pathway and the pyruvate oxidoreductase complex, and the overexpression of the regulator of the rhamnose catabolic pathway, RhaR.

Methods {#s2}
=======

Bacterial cultivation, strains and plasmids {#s2a}
-------------------------------------------

The bacterial strains and plasmids used in this study are listed in Table [1](#DKP203TB1){ref-type="table"}.

###### 

Bacterial strains and plasmids

  Strain or plasmid        Relevant characteristics                                                                                                 Source or reference
  ------------------------ ------------------------------------------------------------------------------------------------------------------------ ---------------------
  Strains                                                                                                                                           
   *B. thetaiotaomicron*                                                                                                                            
    VPI-5482               clinical isolate: wild-type                                                                                              ATCC 29148
    Tn Met^R^              VPI-5482 containing the Tn*4400′* transposon from pYT646B; (Tc^r^)                                                       this study
    *rhaR*^(+)^            VPI-5482 containing *rhaR* gene on pLYLrhaR in cytoplasm; (Tc^r^)                                                        this study
   *E. coli*                                                                                                                                        
    DH5α                   F^−^*end A1 hsdR17*(r~k~^−^ m~k~^+^) *supE44 thi-l* mutant *recA1 gyrA96 relA1*Δ(*argF-lacZYA*)U169 Φ80d*lacZ*M15        15
    S17-1                  contains the transfer functions of RP4 integrated in the chromosome; *recA* Tp^r^ Tra~RP4~                               37
  Plasmids                                                                                                                                          
    pYT646B                delivery vector carrying Tn*4400′* transposon                                                                            17
    pLYL01                 2.6 kb SstI fragment containing the *tetQ* gene from pNFD13-2 cloned into the AatII site of pFD160R; Ap^r^ (Tc^r^) Mob   22
    pLYLrhaR               pLYL01 containing *rhaR* and 239 bp upstream of *rhaR*; Ap^r^ (Tc^r^) Mob                                                14

Tc^r^, tetracycline-resistant; Ap^r^, ampicillin-resistant; Tp^r^, trimethoprim-resistant; Mob, mobilization region on plasmid.

Parentheses around the antibiotic resistance phenotype indicate that it is expressed only in *E. coli*. If there are no parentheses, then the antibiotic resistance phenotype is expressed in *B. thetaiotaomicron* only.

*B. thetaiotaomicron* cultures were grown anaerobically in brain heart infusion broth supplemented with haemin, menadione and cysteine (BHIS) or BHIS agar (1.5% w/v)^[@DKP203C13]^ as previously described.^[@DKP203C14]^ *Escherichia coli* strains were grown with aeration in Luria-Bertani (LB) broth^[@DKP203C15]^ or on LB agar plates (1.5% w/v) at 37°C. The antibiotics gentamicin (200 mg/L), ampicillin (100 mg/L), tetracycline (2 mg/L) and erythromycin (10 mg/L) were added to BHIS or LB whenever necessary. *E. coli* strains carrying plasmids were grown in LB medium supplemented with ampicillin (100 mg/L). Carbohydrate utilization studies were performed by growing *B. thetaiotaomicron* in defined medium (DM)^[@DKP203C16]^ supplemented with 0.1% of either glucose (DMG) or rhamnose (DMR) (Sigma-Aldrich) as the sole carbon source. Growth of the organisms was measured as an increase in optical density at 600 nm (OD~600~) over time. Metronidazole survival studies were performed by growing *B. thetaiotaomicron* cultures to mid-exponential phase in DMR or DMG broth followed by exposure to 15 mg/L metronidazole. Viable counts were determined anaerobically at various timepoints by plating culture dilutions in triplicate on BHIS agar plates and incubation at 37°C for 72 h.

Tn4400′ transposon mutagenesis, Southern hybridization and identification of the transposon insertion site {#s2b}
----------------------------------------------------------------------------------------------------------

The construction of a *B. thetaiotaomicron* VPI-5482 transposon mutant library was carried out using the transposon delivery vector, pYT646B, and the conjugation mutagenesis method of Tang and Malamy.^[@DKP203C17]^ Selection of the transconjugant colonies was performed anaerobically by plating the conjugation mixture onto BHIS agar plates containing gentamicin and either tetracycline or erythromycin. Plasmid rescue was carried out according to Chen *et al.*^[@DKP203C18]^ Putative metronidazole-resistant mutants were screened on BHIS agar plates containing metronidazole ranging in concentration from 0.5 to 8 mg/L. The mutant *B. thetaiotaomicron* Tn Met^R^ was selected for further study. Southern blot analysis was performed according to standard protocols^[@DKP203C15]^ using genomic DNA (20 µg) of both *B. thetaiotaomicron* VPI-5482 and the *B. thetaiotaomicron* Tn Met^R^ mutant, as well as 20 ng of the 13.1 kb transposon delivery vector, pYT646B, each digested to completion with restriction enzyme PvuII.^[@DKP203C15]^ *B. thetaiotaomicron* total genomic DNA was prepared according to the method of Wehnert *et al.*^[@DKP203C19]^ and *E. coli* plasmid DNA was prepared by the alkali-hydrolysis method of Ish-Horowicz and Burke.^[@DKP203C20]^ The DNA probe used for hybridization was a 0.9 kb internal fragment of the pYT646B *tetQ* gene generated by digesting it with SacI and EcoRI. Hybridization and detection procedures were performed according to the manufacturers\' instructions. For identification of the transposon insertion site, genomic DNA from the mutant was digested with HindIII and the fragment adjacent to the transposon was isolated by plasmid rescue.^[@DKP203C18]^ The chromosomal DNA in the resulting ampicillin-resistant plasmid was sequenced using primer L58, derived from IS*4400*R in the transposon.^[@DKP203C18]^ The primers listed in Table [2](#DKP203TB2){ref-type="table"} were used to amplify the 5′ and 3′ junction ends of the transposon insertion in the *B. thetaiotaomicron* Tn met^R^ chromosomal DNA. The PCR fragments obtained were purified using the High Pure PCR Cleanup Kit (Roche) and sequenced as previously described.^[@DKP203C14]^ *B. thetaiotaomicron* VPI-5482 sequence data were obtained from the NCBI website (GenBank accession number NC_004663). Analysis was done using the BLAST algorithm^[@DKP203C21]^ and DNAMAN software V4.13.

###### 

Oligonucleotides used for PCR

  Designation         5′--3′ sequence                    Use                                  Source or reference
  ------------------- ---------------------------------- ------------------------------------ ---------------------
  L58                 CAA TAA TGG ACC TCG TAA AAG        Tn junction PCR and plasmid rescue   17
  TnOF                AAT CGT ACA TTC CAT GGC            Tn junction PCR                      this study
  TnRR                ACC GAA TTT GCG GTC TCC AT         Tn junction PCR                      this study
  Primer *c*          TAG CAA ACT TTATCC ATT CAG         Tn junction PCR                      18
  iKF                 CCGTTATCTAAGCGGTGCC                DNA probe rhaK                       14
  iKR                 CCGAAATTCTCTTCTTGCAGT              DNA probe rhaK                       14
  iIF                 GCAATATTGATGAACTGCGTGCC            DNA probe rhaI                       14
  iIR                 GATTTCTGCAATGAAATCTTCGC            DNA probe rhaI                       14
  iPF                 GAAAATCGTCCGGCACTTGCC              DNA probe rhaP                       14
  iPR                 TCATACCATCCGCTTCGAAGC              DNA probe rhaP                       14
  iAF                 TATAGCCATCGGTAGCTTTTGCC            DNA probe rhaA                       14
  iAR                 ATTACTAAAGGTTACGTTCAGCGCC          DNA probe rhaA                       14
  iOF                 CTTATTTCGGTGCAGGATGCC              DNA probe fucO                       14
  iOR                 CGAACATATCGCTCATAGCCC              DNA probe fucO                       14
  iRF                 GCTGAAGGAGCATCC GTC                DNA probe rhaR                       14
  iRR                 GTCTCATCGCCAGTTCCTCC               DNA probe rhaR                       14
  16SF                AGAGTTTGATCTTGGCTCAG               DNA probe 16S rRNA                   14
  16SR                ACGGTTACCTTGTTACGACTT              DNA probe 16S rRNA                   14
  [c]{.smallcaps}RF   GTGAGGAAGAGGATTCTCCGG              *rhaR* in pLYL01                     14
  cRR                 ACAGATTTAAACGGAAAGCTTAAACTACATCG   *rhaR* in pLYL01                     14

RNA extraction and semi-quantitative dot blot hybridization {#s2c}
-----------------------------------------------------------

*B. thetaiotaomicron* wild-type and mutant cells for RNA extraction were grown anaerobically to late exponential phase in DMR or DMG and the total RNA was isolated.^[@DKP203C14]^ RNA was treated with DNaseI and quantified using the NanoDrop® ND-100 spectrophotometer (NanoDrop Technologies, Inc.). For semi-quantitative RNA hybridization studies, equal amounts (1 µg) of the *B. thetaiotaomicron* RNA were spotted in equal volumes (2 µL) onto a nylon membrane (Roche). Hybridization and detection procedures were performed according to the manufacturer\'s instructions (Roche). Internal fragments of the genes of interest were used as DNA probes for transcriptional hybridization studies. These were prepared by PCR amplification using gene-specific primers (Table [2](#DKP203TB2){ref-type="table"}). The 16S rRNA gene of *B. thetaiotaomicron* VPI-5482 was used as an internal control (Table [2](#DKP203TB2){ref-type="table"}). The PCR, DNA hybridization, detection procedures and analysis were carried out as previously described by Patel *et al.*^[@DKP203C14]^ Signal intensities were measured using a densitometer and analysed with GeneSnap 6.05 software (Synoptics Ltd). Results from duplicate experiments were expressed as the ratio of the gene-specific transcription signal of mutant cells as compared with wild-type cells (induction ratio).

Construction of B. thetaiotaomicron rhaR overexpresser strain {#s2d}
-------------------------------------------------------------

The full-length *rhaR* gene, including 239 bp upstream of the gene, was PCR amplified using primers cRF and cRR (Table [2](#DKP203TB2){ref-type="table"}). The PCR product was digested with HindIII and XmnI, cloned into the HindIII and SmaI sites of the shuttle vector pLYL01^22^ and transformed into *E. coli* DH5α. The resultant plasmid, pLYLrhaR, was extracted, purified and retransformed into *E. coli* S17-1 according to standard methods.^[@DKP203C15]^ Mobilization of pLYLrhaR from *E. coli* S17-1 (pLYLrhaR) into *B. thetaiotaomicron* VPI-5482 was performed by the conjugation procedure of Li *et al.*^[@DKP203C22]^ The resulting transconjugant, *B. thetaiotaomicron rhaR*^(+)^, was grown on BHIS agar with tetracycline (2 mg/L).

Preparation of cell-free extracts (CFEs) and enzyme assays {#s2e}
----------------------------------------------------------

*B. thetaiotaomicron* VPI-5482 cultures for CFEs were grown anaerobically to late log phase in DMR broth. Cells were harvested by centrifugation (8 K, 4°C, 10 min). Pellets were washed three times under anaerobic conditions in 10 mM Tris--HCl, pH 8.0 (for the lactate dehydrogenase assay) or 10 mM phosphate buffer with 250 µM β-mercaptoethanol, pH 7.0 (for the pyruvate oxidoreductase assay), and resuspended in 5 mL of the same buffers, respectively. Cells were disrupted by sonication using an MSE sonicator at an amplitude of 18--24 µm for periods of 30 s/mL of cell suspension in tubes chilled at 0°C. Cell debris was removed by centrifugation (8 K, 4°C, 20 min). The supernatant was collected (CFE) and protein concentrations were determined using Bio-Rad reagents according to the manufacturer\'s instructions (Bio-Rad Laboratories). Lactate dehydrogenase activity was measured anaerobically at 37°C by the rate of decrease in absorbance of NADH at a wavelength of 340 nm using a Beckman DU®530 Lifescience UV/Vis Spectrophotometer according to the method of Abbe *et al.*^[@DKP203C23]^ Enzyme activity was recorded as μM NADH/mg of protein/min at 340 nm. Pyruvate oxidoreductase activity was measured spectrophotometrically at an absorbance of 600 nm using a Beckman DU®530 Lifescience UV/Vis Spectrophotometer, with methyl viologen as the electron acceptor at 37°C under anaerobic conditions using the method of Lindmark and Müller.^[@DKP203C24]^ The enzyme activity was recorded as μM methyl viologen/mg of protein/min at 600 nm. All the experiments were performed in triplicate.

Results and discussion {#s3}
======================

Isolation of the metronidazole-resistant B. thetaiotaomicron mutant {#s3a}
-------------------------------------------------------------------

Transposon mutagenesis was used to create metronidazole-resistant *B. thetaiotaomicron* mutants.^[@DKP203C17]^ Tetracycline-resistant transconjugants were detected at frequencies of 2 × 10^−6^ to 4 × 10^−5^ per *E. coli* donor cell. An average of 40% of tetracycline-resistant transconjugants were co-integrates, compared with the 4% co-integrate formation in *B. fragilis* reported by Tang and Malamy.^[@DKP203C17]^ The *B. thetaiotaomicron* transposon mutant bank (∼2000 isolates) was screened for metronidazole resistance on BHIS agar using metronidazole concentrations varying from 0.5 to 8 mg/L. A mutant, *B. thetaiotaomicron* Tn Met^R^, was isolated with an MIC of 8 mg/L metronidazole compared with the wild-type, which had an MIC of 0.8 mg/L.

Location of the transposon insertion {#s3b}
------------------------------------

Southern hybridization confirmed the presence of a single transposon insertion within the chromosome of the *B. thetaiotaomicron* Tn Met^R^ mutant (data not shown). Plasmid rescue and junction PCR of the chromosomal DNA were performed in order to determine the precise location of the transposon within the mutant. The transposon insertion was found to be 141 bp upstream of *rhaR*, the gene encoding the positive transcriptional regulator of rhamnose catabolism in *B. thetaiotaomicron* (Figure [1](#DKP203F1){ref-type="fig"}a and b). We have demonstrated previously that this region contains the *rhaR* gene promoter sequence.^[@DKP203C14]^

![Genomic arrangement of the rhamnose gene cluster in *B. thetaiotaomicron* VPI-5482 (accession number NC 004663) and the *B. thetaiotaomicron* Tn Met^R^ metronidazole-resistant mutant. (a) Position of the transposon insertion site. P~KIAPO~ and P~R~ indicate the two promoters that have been identified using sequencing and bioinformatic analysis.^14^ The dashed arrow shows the position of the Tn*4400′* transposon insertion. (b) Schematic representation (not to scale) of the transposon insertion between *rhaO* and *rhaR*. IS*4400*L and IS*4400*R, insertion sequence elements; arrows indicate positions of primers used to confirm the insertion site (Table [2](#DKP203TB2){ref-type="table"}); *tetQ*, gene expressing tetracycline resistance in *Bacteroides* species; *bla*, gene expressing β-lactamase (ampicillin resistance) in *E. coli*; *rhaO* and *rhaR*, chromosomal genes of *B. thetaiotaomicron* VPI-5482.](dkp20301){#DKP203F1}

Growth studies under inducing conditions {#s3c}
----------------------------------------

Growth studies were performed in order to investigate the effect of [l]{.smallcaps}-rhamnose or [d]{.smallcaps}-glucose on the growth of the metronidazole-resistant mutant. Results indicated that the mutant strain grown in DMR attained a higher cell density after 10 h when compared with the parent strain, with OD~600~ values of 1.00 ± 0.02 and 0.65 ± 0.03, respectively. There was no significant difference in the cell density of the wild-type and mutant when cells were grown in DMG. This observation suggested that the transposon was improving the capacity of the cells to utilize rhamnose, possibly through increasing the levels of RhaR, the positive transcriptional regulator. The transposon did not, however, appear to affect the catabolism of glucose in the mutant cells.

Effect of the transposon on transcription {#s3d}
-----------------------------------------

The levels of transcription of the genes of the rhamnose cluster were examined to determine if this was related to the enhanced growth of the Met^R^ mutant when compared with the wild-type. Semi-quantitative transcriptional dot blot hybridization studies were performed using RNA extracted from cells grown in DMR or DMG. Results indicated that the transposon insertion in the intergenic region upstream of *rhaR* caused increased transcription of all the rhamnose genes in *B. thetaiotaomicron* Tn Met^R^ as compared with the wild-type strain. In the presence of rhamnose, the genes *rhaKIPAOR* all showed an increase in transcription, expressed as induction ratios of mutant versus wild-type, of 3.4, 3.8, 3.4, 4.4, 3.4 and 1.7, respectively. During growth in glucose, an increase in transcription of these genes was also seen, with induction ratios of 11.1, 19.5, 14.4, 18.8, 15.5 and 1.5, respectively. The internal control 16S rRNA gene was transcribed at the same level in both wild-type and mutant strains under both growth conditions. The results show that even a relatively low level of increase in transcription of the positive regulator, RhaR, can bring about higher levels of transcription of all the genes of the rhamnose operon, even in the absence of rhamnose. In the presence of rhamnose, increased transcription resulted in improved utilization of the substrate and hence better growth as compared with the wild-type parent. During growth in glucose, the increased transcription of the rhamnose catabolic genes brought no additional nutrient benefit to the mutant cells and the same growth response as the wild-type was observed.

Based on the location of the transposon and the orientation of IS*4400*L relative to the transcriptional direction of *rhaR* (Figure [1](#DKP203F1){ref-type="fig"}b), it is possible that the IS element could be acting as an additional promoter leading to increased transcription. Figure [2](#DKP203F2){ref-type="fig"} illustrates the DNA sequence obtained from sequence analysis of the transposon insertion site relative to the *rhaR* promoter region and coding sequence. Three possible typical *Bacteroides* putative −7 hexamers (consensus TAnnTTTG) were identified within the IS*4400*L sequence. This is in keeping with the findings of Bayley *et al.*^[@DKP203C25]^ who first described the *B. fragilis* consensus promoter and reported its presence in the IS*4351* element, which is identical to IS*4400* used in this study. It is not unusual for IS elements to act as strong promoters and activate genes^[@DKP203C26],[@DKP203C27]^ and their role in naturally occurring antibiotic resistance is well documented. For example, Haggoud *et al.*^[@DKP203C28]^ first identified the IS*1168* insertion sequence as being located upstream of the nitroimidazole resistance genes (*nim*), and Soki *et al.*^[@DKP203C29]^ reported that nine *nimA* genes were activated by IS*1168* and three of the *nimC* genes were activated by IS*1170*. In *B. fragilis*, Rogers *et al.*^[@DKP203C30]^ associated the *IS1224* insertion upstream of the *cepA* β-lactamase gene with up-regulation and Podglajen *et al.*^[@DKP203C31]^ reported that IS*1186* activated the expression of the metallo-β-lactamase *cfiA* gene, causing resistance to carbapenems. They later identified the typical *Bacteroides* consensus promoter sequences within two IS elements, IS*1187* and IS*1188*, that were found upstream of *cfiA*.^[@DKP203C32]^ Based on the analysis of the IS*4400*L in relation to RhaR, it is likely that these consensus promoter elements within the IS*4400* element are increasing the activation of the *rhaR* gene, as observed in the transcriptional studies.

![Position of IS*4400*L in relation to the transcriptional start site of *rhaR*. Nucleotide sequence of IS*4400*L (italics) upstream of the *B. thetaiotaomicron rhaR* promoter region and nucleotide sequence; −7 and −33 promoter recognition sequences, the +1 transcriptional start site (bold underlined) and the ATG start codon of *rhaR* (bold, box) are shown. The putative −7 hexamers within the IS element are shown in bold italics and are underlined.^38^](dkp20302){#DKP203F2}

Metronidazole resistance {#s3e}
------------------------

The transposon insertion in the intergenic region between *rhaO* and *rhaR* was shown to increase the transcription of the rhamnose genes in *B. thetaiotaomicron* Tn Met^R^. It was, therefore, possible that higher levels of RhaR were causing the metronidazole resistance phenotype. In order to test this hypothesis, RhaR, the positive transcriptional regulator of the rhamnose operon,^[@DKP203C14]^ with its putative promoter region, was overexpressed in *B. thetaiotaomicron* VPI-5482 through introducing the *rhaR* gene into the parent strain on a multicopy plasmid to create *B. thetaiotaomicron rhaR*^(+)^. Overexpression of the rhamnose genes in this strain was tested at the transcriptional level in defined medium supplemented with rhamnose, and the results indicated that overexpression of the RhaR protein resulted in increased transcription of these genes (data not shown). In order to test the metronidazole resistance phenotype, cells grown in defined medium supplemented with rhamnose or glucose were exposed to 15 mg/L metronidazole for 40 min. Results showed that the log~10~ of the surviving fractions of the *B. thetaiotaomicron* Tn Met^R^ mutant and *B. thetaiotaomicron rhaR*^(+)^, grown in DMR, were −1.65 (±0.007) and −1.88 (±0.010), respectively. These were more resistant than the parent strain, which had a log~10~ surviving fraction of only −2.78 (±0.001). The *B. thetaiotaomicron* Tn Met^R^ mutant cells grown in DMG also showed metronidazole resistance relative to the parental strain, with the log surviving fractions of the mutant and wild-type being −1.75 (±0.013) and −2.62 (±0.001), respectively. This result supports the previously observed metronidazole resistance during isolation of the mutant on BHIS agar, a glucose-containing medium. These data represent the mean values of three experiments, with the standard deviation for the experiments shown in brackets. These results confirm the relationship between increased levels of RhaR and the observed metronidazole resistance, and demonstrate that the phenotype is not directly dependent on the catabolism of rhamnose, but suggest an additional as yet unknown regulatory role for the RhaR protein in relation to metronidazole resistance.

Pyruvate oxidoreductase and lactate dehydrogenase activity {#s3f}
----------------------------------------------------------

The improved growth and a metronidazole resistance phenotype observed in both *B. thetaiotaomicron* Tn Met^R^ and *B. thetaiotaomicron rhaR*^(+)^ during growth in the presence rhamnose could be due to increased expression of RhaR affecting the enzymes responsible for metronidazole activation. Given the proposed role of pyruvate oxidoreductase in metronidazole activation in anaerobes, and the role of lactate dehydrogenase in catabolism, biochemical assays were undertaken to determine the activity of the lactate dehydrogenase and pyruvate oxidoreductase in the metronidazole-resistant strains during growth in DMR (Table [3](#DKP203TB3){ref-type="table"}). The results showed that the lactate dehydrogenase activity of *B. thetaiotaomicron* Tn Met^R^ and *B. thetaiotaomicron rhaR*^(+)^, during growth in DMR, was 4--5 times higher than *B. thetaiotaomicron* VPI-5482, whereas pyruvate oxidoreductase activity in these resistant strains was 7--10 times lower in comparison with the parent strain (Table [3](#DKP203TB3){ref-type="table"}). These results suggested that the lower pyruvate oxidoreductase activity observed in the resistant strains could be contributing to the observed metronidazole resistance phenotype through a lack of metronidazole activation.

###### 

Enzymatic activity of lactate dehydrogenase and pyruvate oxidoreductase during growth in rhamnose

  Strain                            Lactate dehydrogenase^a^   Pyruvate oxidoreductase^b^
  --------------------------------- -------------------------- ----------------------------
  *B. thetaiotaomicron* VPI-5482    3.24 (±3.27)               0.230 (±0.06)
  *B. thetaiotaomicron* Tn Met^R^   16.23 (±6.04)              0.035 (±0.05)
  *B. thetaiotaomicron rhaR*^(+)^   12.08 (±3.50)              0.022 (±0.02)

Data are the mean values of three experiments (±SD).

^a^Enzymatic activity expressed as μM NADH/mg of protein/min.

^b^Enzymatic activity expressed as μM methyl viologen/mg of protein/min.

The mechanism of metronidazole resistance in bacteria is not well understood. However, *in vitro* studies have shown that resistant strains displayed higher levels of lactate or lactate dehydrogenase and, on occasion, no detectable levels of pyruvate oxidoreductase, a key enzyme that is thought to activate metronidazole.^[@DKP203C5]^ There have been no previous reports on lactate dehydrogenase or pyruvate oxidoreductase activity in any *B. thetaiotaomicron* metronidazole-resistant strains. Narikawa *et al.*,^[@DKP203C9]^ however, reported high levels of lactate dehydrogenase in a *B. fragilis* metronidazole-resistant strain. In a more recent study, Diniz *et al.*^[@DKP203C8]^ studied a *B. fragilis* metronidazole-resistant mutant strain, generated by exposure to a sub-lethal concentration of metronidazole, and reported that lactate dehydrogenase activity was up-regulated, but flavodoxin was down-regulated, and there was no detectable pyruvate oxidoreductase activity in the resistant strain. They could not, however, recreate the level of metronidazole resistance observed in the spontaneous mutant by targeted genetic knock-out of either the pyruvate-ferredoxin oxidoreductase gene (*porA*) or flavodoxin genes. It is, therefore, possible that during growth in rhamnose metronidazole resistance in *B. thetaiotaomicron* Tn Met^R^ and *B. thetaiotaomicron rhaR*^(+)^ could be attributed to the lack of metronidazole activation via an altered electron flux driven by the up-regulation of rhamnose catabolism. It is possible that any mutations that give rise to the up-regulation of catabolic pathways associated with a concomitant decrease in pyruvate oxidoreductase activity generate metronidazole resistance within the *Bacteroides* spp.

The metronidazole resistance phenotype was, however, also seen in the *B. thetaiotaomicron* Tn Met^R^ mutant cells grown in glucose, where the products of rhamnose catabolism would not have been a factor. While the results in the presence of rhamnose suggested that resistance was potentially due to reduced activation of metronidazole, the fact that the resistance phenotype was also observed in the presence of glucose makes this unlikely. It is, therefore, probable that the RhaR protein encoded by the *rhaR* gene may also possess additional, as yet unidentified, regulatory functions outside of the rhamnose operon that could affect the cellular responses to metronidazole. Xu *et al.*^[@DKP203C33]^ analysed the *B. thetaiotaomicron* genome sequence and observed that transcriptional regulatory genes, many of them of unknown function, are particularly well represented. We have previously reported that the RhaR protein shows conserved consensus domains typical of transcriptional regulators from the AraC helix-turn-helix (AraC/XylS) family of one-component sensor-regulator proteins.^[@DKP203C14]^ Members of the AraC family have been characterized as being involved in regulating three types of systems, namely pathogenesis, carbon metabolism and certain stress responses, and in the context of regulating stress responses, the proteins exert their regulatory role only when they are overproduced.^[@DKP203C34],[@DKP203C35]^ We have previously shown that the *reg* gene product of *B. fragilis*, also a member of the AraC family, although lacking the putative cupin superfamily domain, is involved in cell survival following exposure to several damaging agents, including metronidazole.^[@DKP203C36]^ An equivalent gene, BT 1847, is present in the *B. thetaiotaomicron* genome. It remains to be determined if overexpression of the RhaR protein of *B. thetaiotaomicron* Tn Met^R^ is functioning in a similar way to improve cell survival in the presence of metronidazole damage by inducing transcription of other, as yet unidentified, genes. Future work will involve proteomic comparison of the *B. thetaiotaomicron* wild-type and *B. thetaiotaomicron* Tn Met^R^ mutant strains to identify the proteins that are up-regulated in response to the overexpression of the RhaR protein.

This is the first study to report a link between a carbohydrate catabolism regulatory protein and metronidazole resistance and presents a potentially novel mechanism for the generation of metronidazole resistance in *Bacteroides* spp.
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